Pathway Diagnostics Corp.

3003 Malibu Canyon Road,
Malibu, California 90265
United States,
(310) 774-3555
www.pathwaydx.com

Pathway Diagnostics Corp. is a full-service biomarker assay development and commercialization company that uniquely combines expertise in clinical biomarker diagnostics with access to intellectual property, a broad range of technology platforms, and full-service central laboratory for clinical trials that is licensed under CLIA/CAP and compliant with GLP/GCP regulations.

Pathway Diagnostics was acquired by Quest Diagnostics on December 09, 2008.

Join Mergr to view all 124 acquisitions of life science companies in 2008, including 20 acquisitions by private equity firms, and 104 by strategics.

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2008. The largest life science acquisition in 2008 was Alpharma Pharmaceuticals - which was acquired by King Pharmaceuticals for $16.0B.

Join Mergr to view this profile - and discover more life science acquisitions of companies like Pathway Diagnostics.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.5K Private Equity Firms
  • 123K M&A Transactions
  • 132K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.9K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.